BG99885A - Pyrene-pyridine derivatives - Google Patents
Pyrene-pyridine derivativesInfo
- Publication number
- BG99885A BG99885A BG99885A BG9988595A BG99885A BG 99885 A BG99885 A BG 99885A BG 99885 A BG99885 A BG 99885A BG 9988595 A BG9988595 A BG 9988595A BG 99885 A BG99885 A BG 99885A
- Authority
- BG
- Bulgaria
- Prior art keywords
- pyridine derivatives
- dopamine
- pyrene
- substituted
- receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB939304111A GB9304111D0 (en) | 1993-03-01 | 1993-03-01 | Therapeutic agents |
GB939316275A GB9316275D0 (en) | 1993-08-05 | 1993-08-05 | Therapeutic agents |
PCT/GB1994/000337 WO1994020497A1 (en) | 1993-03-01 | 1994-02-21 | Pyrrolo-pyridine derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
BG99885A true BG99885A (en) | 1996-02-29 |
Family
ID=26302519
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG99885A BG99885A (en) | 1993-03-01 | 1995-08-24 | Pyrene-pyridine derivatives |
Country Status (20)
Country | Link |
---|---|
US (1) | US5432177A (fi) |
EP (1) | EP0623618A3 (fi) |
JP (1) | JP2710751B2 (fi) |
KR (1) | KR960701052A (fi) |
CN (1) | CN1118598A (fi) |
AU (1) | AU674373B2 (fi) |
BG (1) | BG99885A (fi) |
BR (1) | BR9406128A (fi) |
CA (1) | CA2116213A1 (fi) |
CZ (1) | CZ224195A3 (fi) |
FI (1) | FI954088A (fi) |
HU (1) | HUT71799A (fi) |
IL (1) | IL108729A0 (fi) |
NO (1) | NO953406L (fi) |
NZ (1) | NZ261593A (fi) |
PL (1) | PL310443A1 (fi) |
SI (1) | SI9400091A (fi) |
SK (1) | SK106395A3 (fi) |
WO (1) | WO1994020497A1 (fi) |
YU (1) | YU9194A (fi) |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5622950A (en) * | 1993-03-01 | 1997-04-22 | Merck, Sharp & Dohme Ltd. | Pyrrolo-pyridine derivatives |
ES2134929T3 (es) * | 1993-03-01 | 1999-10-16 | Merck Sharp & Dohme | Derivados de pirrolo-piridina como ligandos para receptores de dopamina. |
GB9305644D0 (en) * | 1993-03-18 | 1993-05-05 | Merck Sharp & Dohme | Therapeutic agents |
GB9305641D0 (en) * | 1993-03-18 | 1993-05-05 | Merck Sharp & Dohme | Therapeutic agents |
GB9305623D0 (en) * | 1993-03-18 | 1993-05-05 | Merck Sharp & Dohme | Therapeutic agents |
GB9306578D0 (en) * | 1993-03-30 | 1993-05-26 | Merck Sharp & Dohme | Therapeutic agents |
US5817679A (en) * | 1993-04-01 | 1998-10-06 | University Of Virginia | 7-Azabicyclo 2.2.1!-heptane and -heptene derivatives as cholinergic receptor ligands |
US6060473A (en) * | 1993-04-01 | 2000-05-09 | Ucb S.A. - Dtb | 7-azabicyclo[2.2.1]-heptane and -heptene derivatives as cholinergic receptor ligands |
AU6435594A (en) * | 1993-04-15 | 1994-11-08 | Merck Sharp & Dohme Limited | Indole derivatives as dopamine d4 antagonists |
AU701227B2 (en) * | 1993-09-10 | 1999-01-21 | Cytomed, Inc | Epibatidine and derivatives thereof as cholinergic receptor agonists and antagonists |
US6117889A (en) * | 1994-04-01 | 2000-09-12 | University Of Virginia | 7-Azabicyclo-[2.2.1]-heptane and -heptene derivatives as analgesics and anti-inflammatory agents |
CA2190501A1 (en) * | 1994-05-19 | 1995-11-30 | Jose Luis Castro Pineiro | Piperazine, piperidine and tetrahydropyridine derivatives of indol-3-ylalkyl as 5-ht1d-alpha agonists |
CZ285090B6 (cs) * | 1994-09-30 | 1999-05-12 | Pfizer Inc. | 2,7-Disubstituovaný oktahydro-1H-pyrido-[1,2-a]pyrazinové deriváty a farmaceutické prostředky na jejich bázi |
GB9423460D0 (en) * | 1994-11-21 | 1995-01-11 | Merck Sharp & Dohme | Therapeutic agents |
WO1996025414A1 (en) * | 1995-02-15 | 1996-08-22 | Pharmacia & Upjohn Company | Imidazo[1,2-a]pyridines for the treatment of cns and cardiac diseases |
GB2298199A (en) * | 1995-02-21 | 1996-08-28 | Merck Sharp & Dohme | Synthesis of azaindoles |
GB9507291D0 (en) * | 1995-04-07 | 1995-05-31 | Merck Sharp & Dohme | Therapeutic agents |
US6187774B1 (en) * | 1996-03-04 | 2001-02-13 | Yoshitomi Pharmaceutical Industries, Ltd. | Fused heterocyclic compounds and pharmaceutical applications thereof |
US5725838A (en) * | 1996-05-31 | 1998-03-10 | Resolution Pharmaceuticals, Inc. | Radiolabeled D4 receptor ligands |
DE19637237A1 (de) * | 1996-09-13 | 1998-03-19 | Merck Patent Gmbh | Piperazin-Derivate |
US5976497A (en) * | 1997-08-04 | 1999-11-02 | Resolution Pharmaceuticals, Inc. | Dopamine D4 receptor ligands |
AU8096798A (en) * | 1997-06-27 | 1999-01-19 | Resolution Pharmaceuticals Inc. | Dopamine d4 receptor ligands |
US6013654A (en) * | 1997-08-14 | 2000-01-11 | Pharmacia & Upjohn Company | Imidazo[1,2-A]pyridines for the treatment of CNS and cardiac diseases |
ES2222219T3 (es) * | 1999-08-12 | 2005-02-01 | Nps Allelix Corp. | Azaindoles que tienen actividad con el receptor de serotonina. |
US6686374B1 (en) | 1999-08-12 | 2004-02-03 | Nps Allelix Corp. | Azaindoles having serotonin receptor affinity |
AR028945A1 (es) * | 2000-06-19 | 2003-05-28 | Lundbeck & Co As H | Derivados de indol |
EA200300084A1 (ru) * | 2000-06-29 | 2003-06-26 | Х.Лундбекк А/С | Производные индола, пригодные для лечения расстройств цнс |
JP4180365B2 (ja) * | 2000-07-31 | 2008-11-12 | エフ.ホフマン−ラ ロシュ アーゲー | ピペラジン誘導体 |
US7432304B2 (en) | 2001-05-30 | 2008-10-07 | The Regents Of The University Of Michigan | Small molecule antagonists of Bcl-2 family proteins |
EP1406631A4 (en) * | 2001-06-13 | 2005-03-23 | Univ Michigan | DOPAMINE RECEPTOR LIGANDS AND CORRESPONDING THERAPEUTIC METHODS |
WO2003038060A2 (en) | 2001-11-01 | 2003-05-08 | The Regents Of The University Of Michigan | Small molecule inhibitors targeted at bcl-2 |
CN100347171C (zh) * | 2002-02-08 | 2007-11-07 | 中国科学院上海原子核研究所 | 一种吡啶类化合物及其制备方法和作为多巴胺d4受体拮抗剂的应用 |
CN1305873C (zh) * | 2002-07-12 | 2007-03-21 | 中国科学院上海原子核研究所 | [18f]氟标记的吡啶类化合物及其制备方法和作为多巴胺d4受体显像剂的应用 |
JP2004123562A (ja) * | 2002-09-30 | 2004-04-22 | Japan Science & Technology Corp | 神経細胞死抑制作用を有する化合物を用いた医薬 |
GB0314967D0 (en) * | 2003-06-26 | 2003-07-30 | Hoffmann La Roche | Piperazine derivatives |
US20070066641A1 (en) * | 2003-12-19 | 2007-03-22 | Prabha Ibrahim | Compounds and methods for development of RET modulators |
CA2550361C (en) | 2003-12-19 | 2014-04-29 | Prabha Ibrahim | Compounds and methods for development of ret modulators |
EA011218B1 (ru) | 2004-03-25 | 2009-02-27 | Дзе Риджентс Оф Дзе Юниверсити Оф Мичиган | Сокристаллы госсипола и их применение |
EP1755597A2 (en) * | 2004-06-17 | 2007-02-28 | Plexxikon, Inc. | Azaindoles modulating c-kit activity and uses therefor |
US7498342B2 (en) * | 2004-06-17 | 2009-03-03 | Plexxikon, Inc. | Compounds modulating c-kit activity |
DE102004054634A1 (de) * | 2004-11-12 | 2006-05-18 | Schwarz Pharma Ag | Azaindolcarboxamide |
EP1885723A2 (en) * | 2005-05-17 | 2008-02-13 | Plexxikon, Inc. | Pyrrolo[2,3-b]pyridine derivatives as protein kinase inhibitors |
TWI432193B (zh) * | 2005-06-22 | 2014-04-01 | Plexxikon Inc | 用於激酶調節的化合物及方法及其適應症 |
US7544685B2 (en) | 2005-08-17 | 2009-06-09 | H. Lundbeck A/S | 2,3-dihydroindole compounds |
MX2008010481A (es) | 2006-02-17 | 2008-12-19 | Memory Pharm Corp | Compuestos que tienen afinado para el receptor f-ht6. |
WO2008063888A2 (en) | 2006-11-22 | 2008-05-29 | Plexxikon, Inc. | Compounds modulating c-fms and/or c-kit activity and uses therefor |
WO2008079909A1 (en) * | 2006-12-21 | 2008-07-03 | Plexxikon, Inc. | Pyrrolo [2,3-b] pyridines as kinase modulators |
US7872018B2 (en) | 2006-12-21 | 2011-01-18 | Plexxikon, Inc. | Compounds and methods for kinase modulation, and indications therefor |
PE20081581A1 (es) * | 2006-12-21 | 2008-11-12 | Plexxikon Inc | COMPUESTOS PIRROLO[2,3-b]PIRIDINAS COMO MODULADORES DE QUINASA |
JP2010533729A (ja) | 2007-07-17 | 2010-10-28 | プレキシコン,インコーポレーテッド | キナーゼ調節のための化合物と方法、及びそのための適応 |
AR078033A1 (es) | 2009-04-03 | 2011-10-12 | Plexxikon Inc | Una dispersion solida, que contiene al compuesto {3-[5-(4-(cloro-fenil)-1h-pirrolo[2,3-b]piridina-3-carbonil]-2,4-difluor-fenil}-amida del acido propano-1-sulfonico, composiciones y formulaciones que comprenden a dicha dispersion solida; metodos para fabricar dicha dispersion solida, formas 1 y 2 de |
US8546377B2 (en) * | 2009-04-23 | 2013-10-01 | Abbvie Inc. | Modulators of 5-HT receptors and methods of use thereof |
US8518933B2 (en) | 2009-04-23 | 2013-08-27 | Abbvie Inc. | Modulators of 5-HT receptors and methods of use thereof |
US8329724B2 (en) | 2009-08-03 | 2012-12-11 | Hoffmann-La Roche Inc. | Process for the manufacture of pharmaceutically active compounds |
NZ629615A (en) | 2009-11-06 | 2016-01-29 | Plexxikon Inc | Compounds and methods for kinase modulation, and indications therefor |
WO2012074769A1 (en) * | 2010-12-02 | 2012-06-07 | Eli Lilly And Company | 3-substituted-6-(pyridinylmethoxy)-pyrrolopyridine compounds |
US9624213B2 (en) | 2011-02-07 | 2017-04-18 | Plexxikon Inc. | Compounds and methods for kinase modulation, and indications therefor |
AR085279A1 (es) | 2011-02-21 | 2013-09-18 | Plexxikon Inc | Formas solidas de {3-[5-(4-cloro-fenil)-1h-pirrolo[2,3-b]piridina-3-carbonil]-2,4-difluor-fenil}-amida del acido propano-1-sulfonico |
US9150570B2 (en) | 2012-05-31 | 2015-10-06 | Plexxikon Inc. | Synthesis of heterocyclic compounds |
ES2649144T3 (es) * | 2012-11-08 | 2018-01-10 | Pfizer Inc. | Compuestos heteroaromáticos y su uso como ligandos de dopamina D1 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3362956A (en) * | 1965-08-19 | 1968-01-09 | Sterling Drug Inc | 1-[(heterocyclyl)-lower-alkyl]-4-substituted-piperazines |
US3511841A (en) * | 1967-05-29 | 1970-05-12 | Sterling Drug Inc | 1-((4-,5-,6-,and 7-azaindolyl)-lower-alkyl)- 4-substituted-piperazines |
US5422265A (en) * | 1990-12-07 | 1995-06-06 | State Of Oregon, Acting By And Through The State Board Of Higher Education On Behalf Of The Oregon Health Sciences University | DNA sequence for the human dopamine receptor D4 and expression thereof in mammalian cells |
-
1994
- 1994-02-21 CN CN94191350A patent/CN1118598A/zh active Pending
- 1994-02-21 PL PL94310443A patent/PL310443A1/xx unknown
- 1994-02-21 BR BR9406128A patent/BR9406128A/pt not_active Application Discontinuation
- 1994-02-21 CZ CZ952241A patent/CZ224195A3/cs unknown
- 1994-02-21 SK SK1063-95A patent/SK106395A3/sk unknown
- 1994-02-21 NZ NZ261593A patent/NZ261593A/en unknown
- 1994-02-21 WO PCT/GB1994/000337 patent/WO1994020497A1/en not_active Application Discontinuation
- 1994-02-21 HU HU9501871A patent/HUT71799A/hu unknown
- 1994-02-22 SI SI9400091A patent/SI9400091A/sl unknown
- 1994-02-22 EP EP94200426A patent/EP0623618A3/en not_active Withdrawn
- 1994-02-22 CA CA002116213A patent/CA2116213A1/en not_active Abandoned
- 1994-02-22 US US08/200,113 patent/US5432177A/en not_active Expired - Lifetime
- 1994-02-22 IL IL10872994A patent/IL108729A0/xx unknown
- 1994-02-28 AU AU56470/94A patent/AU674373B2/en not_active Ceased
- 1994-03-01 YU YU9194A patent/YU9194A/sh unknown
- 1994-03-01 JP JP6031241A patent/JP2710751B2/ja not_active Expired - Lifetime
-
1995
- 1995-08-24 BG BG99885A patent/BG99885A/xx unknown
- 1995-08-30 NO NO953406A patent/NO953406L/no unknown
- 1995-08-31 KR KR1019950703674A patent/KR960701052A/ko not_active Application Discontinuation
- 1995-08-31 FI FI954088A patent/FI954088A/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2710751B2 (ja) | 1998-02-10 |
FI954088A0 (fi) | 1995-08-31 |
EP0623618A2 (en) | 1994-11-09 |
WO1994020497A1 (en) | 1994-09-15 |
US5432177A (en) | 1995-07-11 |
AU5647094A (en) | 1994-09-08 |
NO953406L (no) | 1995-10-31 |
FI954088A (fi) | 1995-08-31 |
HU9501871D0 (en) | 1995-08-28 |
NZ261593A (en) | 1996-09-25 |
CN1118598A (zh) | 1996-03-13 |
CZ224195A3 (en) | 1996-03-13 |
NO953406D0 (no) | 1995-08-30 |
PL310443A1 (en) | 1995-12-11 |
HUT71799A (en) | 1996-02-28 |
SK106395A3 (en) | 1995-12-06 |
SI9400091A (en) | 1994-12-31 |
IL108729A0 (en) | 1994-05-30 |
BR9406128A (pt) | 1996-02-27 |
AU674373B2 (en) | 1996-12-19 |
CA2116213A1 (en) | 1994-09-02 |
KR960701052A (ko) | 1996-02-24 |
JPH06279442A (ja) | 1994-10-04 |
EP0623618A3 (en) | 1997-04-02 |
YU9194A (sh) | 1997-08-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG99885A (en) | Pyrene-pyridine derivatives | |
IT1271352B (it) | Derivati dell'indolo utili nel trattamento dei disturbi del sistema nervoso centrale | |
DE69407176D1 (de) | Antipsychotische benzimidazolderivate | |
MY126973A (en) | Derivatives of 4-aminopiperidine and their use as a medicament | |
ZA952382B (en) | Naphthalamides as central nervous system agents | |
EA199800340A1 (ru) | Производные пиримидина как антагонисты 5нт2с | |
ES2123810T3 (es) | Heterociclos utiles como antagonistas de neuroquinina. | |
CA2129995A1 (en) | Piperidinyl thiacyclic derivatives | |
KR900000092A (ko) | 신경 장애의 치료에 있어서 유리딘의 약리학적 용도 | |
GR3019782T3 (en) | Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents | |
NZ504040A (en) | Cyclopentene derivatives useful as antagonists of the motilin receptor | |
WO1992007832A3 (en) | Substituted piperazines as central nervous system agents | |
FI945807A0 (fi) | 2,5-diokso-2,5-dihydro-1H-bents/b/atsepiinit NMDA-reseptorin antagonisteina | |
EE04905B1 (et) | Pridasino[4,5-b]indool-1-atseetamiidi derivaatide kasutamine ravimite valmistamiseks perifeersete bensodiasepiiniretseptorite dsfunktsioneerimisegaseotud haiguste raviks | |
ES2080736T3 (es) | Uso de 2,3,4,5-tetrahidro-1h-3-benzazepinas en el tratamiento de trastornos neurologicos. | |
BR9406034A (pt) | Derivados de imidazoloquinoxalinonas como antagonistas de eaa. | |
MY105555A (en) | Heterocyclicguanidines as 5ht 3 antagonists. | |
PT935598E (pt) | Derivados de 3-oxo-pirido (1,2-a)benzimidazole-4-carboxamida alquilo substituidos contendo 5 heteroatomos uteis no tratamento de disturbios do sistema nervoso central | |
DE3780542D1 (en) | Substituierte hexahydroarylchinolizine. | |
DK0789701T3 (da) | Substituerede tetracykliske azepinderivater med 5-HT2-receptoraffinitet | |
BR9914397A (pt) | Derivados da ureidopiperidina como antagonistas seletivos dos receptores nk3 humanos | |
JPS5572193A (en) | 9*100dihydroo4hhbenzo*4*5*cycloheptaa *1*22b*thiophenee4*99imine | |
MX9706967A (es) | Indazolcarboxamidas. |